Interferon beta-1a sc at 25 years: a mainstay in the treatment of multiple sclerosis over the period of one generation-Reference-Cited by-同舟云学术

Interferon beta-1a sc at 25 years: a mainstay in the treatment of multiple sclerosis over the period of one generation

Published:2023-09-11 Issue:11 Volume:19 Page:1343-1359
ISSN:1744-666X
Container-title:Expert Review of Clinical Immunology
language:en
Short-container-title:Expert Review of Clinical Immunology

Author:

Zettl Uwe Klaus¹^ORCID,Rommer Paulus Stefan¹²^ORCID,Aktas Orhan³^ORCID,Wagner Torsten⁴,Richter Joachim⁴,Oschmann Patrick⁵^ORCID,Cepek Lukas⁶,Elias-Hamp Birte⁷,Gehring Klaus⁸^ORCID,Chan Andrew⁹^ORCID,Hecker Michael¹^ORCID

Affiliation:

1. Department of Neurology, Rostock University Medical Center, Rostock, Germany

2. Department of Neurology, Medical University of Vienna, Vienna, Austria

3. Department of Neurology, Medical Faculty, Heinrich Heine University Düsseldorf, Düsseldorf, Germany

4. Merck Healthcare Germany GmbH, Weiterstadt, Germany

5. Department of Neurology, Bayreuth Hospital, Bayreuth, Germany

6. Neurological Group Practice, Ulm, Germany

7. Neurological Private Practice, Hamburg, Germany

8. Neurocenter Itzehoe, Itzehoe, Germany

9. Department of Neurology, Inselspital Bern, University Hospital Bern, Bern, Switzerland

Funder

Merck

Publisher

Informa UK Limited

Subject

Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/1744666X.2023.2248391

Reference193 articles.

1. Interferon β-1a and β-1b for patients with multiple sclerosis: updates to current knowledge

2. Virus interference I, the interferon;Isaacs A;Proc Royal Soc B,1957

3. Interferon-?? in Malignant and Viral Diseases

4. Intrathecal Interferon Reduces Exacerbations of Multiple Sclerosis

5. Comparative effectiveness of beta-interferons and glatiramer acetate for relapsing-remitting multiple sclerosis: systematic review and network meta-analysis of trials including recommended dosages

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Terapiya rasseyannogo skleroza preparatami pervoj linii: uroven' citokinov i vliyanie gerpeticheskoj infekcii;Вестник Российского государственного медицинского университета;2024-06

2. First line therapy for multiple sclerosis: cytokine levels and the impact of herpesvirus infection;Bulletin of Russian State Medical University;2024-06

3. Inborn errors of immunity: A field without frontiers;Immunological Reviews;2023-12-08